Extensive size variability of the GGGGCC expansion in C9orf72 in both neuronal and non-neuronal tissues in 18 patients with ALS or FTD

Human Molecular Genetics

Volumn 24, Issue 11, 2014, Pages 3133-3142

  Nordin, Angelica ^a   Akimoto, Chizuru ^a,b   Wuolikainen, Anna ^a   Alstermark, Helena ^a   Jonsson, Pär ^a   Birve, Anna ^a   Marklund, Stefan L ^a   Graffmo, Karin S ^a   Forsberg, Karin ^a   Brännström, Thomas ^a   Andersen, Peter M ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BRAIN REGION; BRAIN TISSUE; C9ORF72 GENE; CAG REPEAT; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FRONTOTEMPORAL DEMENTIA; GENE; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; MALE; MIDDLE AGED; NERVOUS TISSUE; NUCLEOTIDE REPEAT; ONSET AGE; PRIORITY JOURNAL; PROTEIN DEGRADATION; SOUTHERN BLOTTING; ANTIBODY SPECIFICITY; CEREBELLUM; DISEASE COURSE; GENETIC ASSOCIATION STUDY; GENETICS; NUCLEOTIDE SEQUENCE; PARIETAL LOBE; PATHOLOGY; TANDEM REPEAT;

C9ORF72 PROTEIN, HUMAN; PROTEIN;

AGE OF ONSET; AGED; AMYOTROPHIC LATERAL SCLEROSIS; BASE SEQUENCE; CEREBELLUM; DISEASE PROGRESSION; FEMALE; FRONTOTEMPORAL DEMENTIA; GENETIC ASSOCIATION STUDIES; HUMANS; MALE; MIDDLE AGED; ORGAN SPECIFICITY; PARIETAL LOBE; PROTEINS; TANDEM REPEAT SEQUENCES;

EID: 84930747272     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddv064     Document Type: Article

References (32)

1. Bennion Callister, J. and Pickering-Brown, S.M. (2014) Pathogenesis/genetics of frontotemporal dementia and how it relates to ALS. Exp. Neurol., 262(Pt B), 84-90.
2. DeJesus-Hernandez, M., Mackenzie, I.R., Boeve, B.F., Boxer, A.L., Baker, M., Rutherford, N.J., Nicholson, A.M., Finch, N.A., Flynn, H., Adamson, J. et al. (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron, 72, 245-256.
3. Renton, A.E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J.R., Schymick, J.C., Laaksovirta, H., van Swieten, J.C., Myllykangas, L. et al. (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron, 72, 257-268.
4. Levine, T.P., Daniels, R.D., Gatta, A.T., Wong, L.H. and Hayes, M.J. (2013) The product of C9orf72, a gene strongly implicated in neurodegeneration, is structurally related to DENN Rab-GEFs. Bioinformatics, 29, 499-503.
5. Zhang, D., Iyer, L.M., He, F. and Aravind, L. (2012) Discovery of novel DENN proteins: implications for the evolution of eukaryotic intracellular membrane structures and human disease. Front. Genet., 3, 283.
6. Farg, M.A., Sundaramoorthy, V., Sultana, J.M., Yang, S., Atkinson, R.A., Levina, V., Halloran, M.A., Gleeson, P.A., Blair, I.P., Soo, K.Y. et al. (2014) C9ORF72, implicated in amytrophic lateral sclerosis and frontotemporal dementia, regulates endosomal trafficking. Hum. Mol. Genet., 23, 3579-3595.
7. Byrne, S., Heverin, M., Elamin, M.,Walsh, C. and Hardiman, O. (2013) Intermediate repeat expansion length in C9orf72 may be pathological in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Frontotemporal Degener., 15, 148-150.
8. Gijselinck, I., Van Langenhove, T., van der Zee, J., Sleegers, K., Philtjens, S., Kleinberger, G., Janssens, J., Bettens, K., Van Cauwenberghe, C., Pereson, S. et al. (2012) AC9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study. Lancet Neurol., 11, 54-65.
9. Cooper-Knock, J., Higginbottom, A., Connor-Robson, N., Bayatti, N., Bury, J.J., Kirby, J., Ninkina, N., Buchman, V.L. and Shaw, P.J. (2013) C9ORF72 transcription in a frontotemporal dementia case with two expanded alleles. Neurology, 81, 1719-1721.
10. Cooper-Knock, J., Walsh, M.J., Higginbottom, A., Robin Highley, J., Dickman, M.J., Edbauer, D., Ince, P.G., Wharton, S.B., Wilson, S.A., Kirby, J. et al. (2014) Sequestration of multiple RNA recognition motif-containing proteins by C9orf72 repeat expansions. Brain, 137, 2040-2051.
11. Lee, Y.B., Chen, H.J., Peres, J.N., Gomez-Deza, J., Attig, J., Stalekar, M., Troakes, C., Nishimura, A.L., Scotter, E.L., Vance, C. et al. (2013) Hexanucleotide repeats in ALS/FTD form length-dependent RNA foci, sequester RNA binding proteins, and are neurotoxic. Cell Rep., 5, 1178-1186.
12. Ash, P.E., Bieniek, K.F., Gendron, T.F., Caulfield, T., Lin, W.L., Dejesus-Hernandez, M., van Blitterswijk, M.M., Jansen-West, K., Paul, J.W., Rademakers, R. et al. (2013) Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS. Neuron, 77, 639-646.
13. Mori, K., Weng, S.M., Arzberger, T., May, S., Rentzsch, K., Kremmer, E., Schmid, B., Kretzschmar, H.A., Cruts, M., Van Broeckhoven, C. et al. (2013) The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. Science, 339, 1335-1338.
14. Zu, T., Liu, Y., Bañez-Coronel,M., Reid, T., Pletnikova, O., Lewis, J., Miller, T.M., Harms, M.B., Falchook, A.E., Subramony, S.H. et al. (2013) RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia. Proc. Natl Acad. Sci. USA, 110, E4968-E4977.
15. Akimoto, C., Volk, A.E., van Blitterswijk, M., Van den Broeck, M., Leblond, C.S., Lumbroso, S., Camu, W., Neitzel, B., Onodera, O., van Rheenen,W. et al. (2014) A blinded international study on the reliability of genetic testing for GGGGCC-repeat expansions in C9orf72 reveals marked differences in results among 14 laboratories. J. Med. Genet., 51, 419-424.
16. Dobson-Stone, C., Hallupp, M., Loy, C.T., Thompson, E.M., Haan, E., Sue, C.M., Panegyres, P.K., Razquin, C., Seijo-Martínez, M., Rene, R. et al. (2013) C9ORF72 repeat expansion in Australian and Spanish frontotemporal dementia patients. PLoS One, 8, e56899.
17. van Blitterswijk, M., DeJesus-Hernandez, M., Niemantsverdriet, E., Murray, M.E., Heckman, M.G., Diehl, N.N., Brown, P.H., Baker, M.C., Finch, N.A., Bauer, P.O. et al. (2013) Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort study. Lancet Neurol., 12, 978-988.
18. Dols-Icardo, O., García-Redondo, A., Rojas-García, R., Sánchez-Valle, R., Noguera, A., Gómez-Tortosa, E., Pastor, P., Hernández, I., Esteban-Pérez, J., Suárez-Calvet, M. et al. (2014) Characterization of the repeat expansion size in C9orf72 in amyotrophic lateral sclerosis and frontotemporal dementia. Hum. Mol. Genet., 23, 749-754.
19. Beck, J., Poulter, M., Hensman, D., Rohrer, J.D., Mahoney, C.J., Adamson, G., Campbell, T., Uphill, J., Borg, A., Fratta, P. et al. (2013) Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population. Am. J. Hum. Genet., 92, 345-353.
20. Bylesjö, M., Rantalainen, M., Cloarec, O., Nicholson, J.K., Holmes, E. and Trygg, J. (2006) OPLS discriminant analysis:combining the strengths of PLS-DA and SIMCA classification. J. Chemometrics, 20, 341-351.
21. Korfage, J.A., Koolstra, J.H., Langenbach, G.E. and van Eijden, T.M. (2005) Fiber-type composition of the human jaw muscles-(part 1) origin and functional significance of fibertype diversity. J. Dent. Res., 84, 774-783.
22. Korfage, J.A., Koolstra, J.H., Langenbach, G.E. and van Eijden, T.M. (2005) Fiber-type composition of the human jaw muscles-(part 2) role of hybrid fibers and factors responsible for inter-individual variation. J. Dent. Res., 84, 784-793.
23. Shih, H.P., Gross, M.K. and Kioussi, C. (2008) Muscle development:forming the head and trunk muscles. Acta Histochem., 110, 97-108.
24. Pearson, C.E., Nichol Edamura, K. and Cleary, J.D. (2005) Repeat instability: mechanisms of dynamic mutations. Nat. Rev. Genet., 6, 729-742.
25. Buchman, V.L., Cooper-Knock, J., Connor-Robson, N., Higginbottom, A., Kirby, J., Razinskaya, O.D., Ninkina, N. and Shaw, P.J. (2013) Simultaneous and independent detection of C9ORF72 alleles with lowand high number of GGGGCC repeats using an optimised protocol of Southern blot hybridisation. Mol. Neurodegener., 8, 12.
26. Fratta, P., Polke, J.M., Newcombe, J., Mizielinska, S., Lashley, T., Poulter, M., Beck, J., Preza, E., Devoy, A., Sidle, K. et al. (2014) Screening a UK amyotrophic lateral sclerosis cohort provides evidence of multiple origins of the C9orf72 expansion. Neurobiol. Aging, 36, 546.e451-547.
27. Poduri, A., Evrony, G.D., Cai, X. and Walsh, C.A. (2013) Somatic mutation, genomic variation, and neurological disease. Science, 341, 1237758.
28. Pamphlett, R., Cheong, P.L., Trent, R.J. and Yu, B. (2013) Can ALS-associated C9orf72 repeat expansions be diagnosed on a blood DNA test alone?. PLoS One, 8, e70007.
29. Andersen, P.M., Abrahams, S., Borasio, G.D., de Carvalho, M., Chio, A., Van Damme, P., Hardiman, O., Kollewe, K.,Morrison, K.E., Petri, S. et al. (2012) EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)-revised report of an EFNS task force. Eur. J. Neurol., 19, 360-375.
30. Neary, D., Snowden, J.S., Gustafson, L., Passant, U., Stuss, D., Black, S., Freedman, M., Kertesz, A., Robert, P.H., Albert, M. et al. (1998) Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology, 51, 1546-1554.
31. Wold, S., Esbensen, K. and Geladi, P. (1987) Principal component analysis. Chemometr. Intell. Lab., 2, 37-52.
32. Trygg, J. and Wold, S. (2002) Orthogonal projections to latent structures (O-PLS). J. Chemometrics, 16, 119-128.